Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
Clinical trial NCT03747484 · TERMINATED
Trial details
- NCT number
- NCT03747484
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-03
- Primary completion
- 2024-01-09
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.